CTOs on the Move

Molyslip (Canada)Inc.

www.molyslip.com

 
Molyslip (Canada)Inc. is a Scarborough, ON-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.molyslip.com
  • 1145 Bellamy Rd N
    Scarborough, ON CAN M1H 1H5
  • Phone: 416.438.5523

Executives

Name Title Contact Details

Similar Companies

Hallcon

Hallcon is a turnkey transportation services partner that has redefined the rider experience to achieve growth for companies, universities, airports, railroads and transit agencies throughout North America. As the industry leader in data analytics, business intelligence and technology integration capabilities, Hallcon provides clients with the insights needed to improve rider health and safety, vehicle reliability, operating performance and rider satisfaction.

Reiland.Com

Reiland.Com is a Marshall, TX-based company in the Business Services sector.

S Jennings Racing

S Jennings Racing is a Tooele, UT-based company in the Business Services sector.

Innovative

Innovative Design at USC is an organization that focuses on design education and accessibility. They coordinate design workshops, guest speakers, events, portfolio reviews, and provide mentorship and networking opportunities to their members.

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, founded in 2006. Formerly known as Miragen Therapeutics, the company rebranded in January 2021. Viridian is dedicated to discovering, developing, and commercializing treatments for serious and rare diseases, utilizing its expertise in antibody discovery and protein engineering. The company’s product pipeline includes Veligrotug (VRDN-001), a monoclonal antibody in Phase 3 clinical trials for thyroid eye disease, and VRDN-003, a next-generation IGF-1R monoclonal antibody also in Phase 3 trials for the same condition. Additionally, Viridian is developing a portfolio of engineered anti-FcRn inhibitors, such as VRDN-006 and VRDN-008, aimed at treating various autoimmune diseases. Viridians mission is to deliver transformative therapies for patients with underserved diseases, emphasizing innovation and patient-centricity.